BeOne Medicines (ONC) Current Leases: 2019-2025
Historic Current Leases for BeOne Medicines (ONC) over the last 7 years, with Sep 2025 value amounting to $15.7 million.
- BeOne Medicines' Current Leases fell 11.15% to $15.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.7 million, marking a year-over-year decrease of 11.15%. This contributed to the annual value of $17.6 million for FY2024, which is 19.93% down from last year.
- Latest data reveals that BeOne Medicines reported Current Leases of $15.7 million as of Q3 2025, which was down 8.80% from $17.2 million recorded in Q2 2025.
- Over the past 5 years, BeOne Medicines' Current Leases peaked at $24.8 million during Q2 2022, and registered a low of $14.0 million during Q1 2021.
- Its 3-year average for Current Leases is $19.7 million, with a median of $18.3 million in 2025.
- Per our database at Business Quant, BeOne Medicines' Current Leases soared by 63.61% in 2022 and then decreased by 24.89% in 2024.
- BeOne Medicines' Current Leases (Quarterly) stood at $21.9 million in 2021, then increased by 9.65% to $24.0 million in 2022, then dropped by 8.70% to $21.9 million in 2023, then dropped by 19.93% to $17.6 million in 2024, then dropped by 11.15% to $15.7 million in 2025.
- Its last three reported values are $15.7 million in Q3 2025, $17.2 million for Q2 2025, and $18.3 million during Q1 2025.